{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:24:47Z","timestamp":1788585887535,"version":"build-2803163510"},"reference-count":14,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2007,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            To test the hypothesis that prolonged culture would enhance the sensitivity of latent tuberculosis detection by a gamma interferon release assay, blood samples from 33 household contacts of Gambian tuberculosis patients were stimulated with\n            <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n            -specific antigens. After 24 h of culture, 66% were positive, compared to 93% after 6 days of culture.\n          <\/jats:p>","DOI":"10.1128\/cvi.00093-07","type":"journal-article","created":{"date-parts":[[2007,4,26]],"date-time":"2007-04-26T05:33:07Z","timestamp":1177565587000},"page":"796-798","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":26,"title":["Extended Culture Enhances Sensitivity of a Gamma Interferon Assay for Latent\n            <i>Mycobacterium tuberculosis<\/i>\n            Infection"],"prefix":"10.1128","volume":"14","author":[{"given":"Ana","family":"Cehovin","sequence":"first","affiliation":[{"name":"Department of Infectious and Tropical Diseases, London School of Hygiene &amp; Tropical Medicine, London, United Kingdom"},{"name":"Medical Research Centre, The Fajara, Banjul, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M.","family":"Cliff","sequence":"additional","affiliation":[{"name":"Department of Infectious and Tropical Diseases, London School of Hygiene &amp; Tropical Medicine, London, United Kingdom"},{"name":"Medical Research Centre, The Fajara, Banjul, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip C.","family":"Hill","sequence":"additional","affiliation":[{"name":"Department of Infectious and Tropical Diseases, London School of Hygiene &amp; Tropical Medicine, London, United Kingdom"},{"name":"Medical Research Centre, The Fajara, Banjul, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger H.","family":"Brookes","sequence":"additional","affiliation":[{"name":"Department of Infectious and Tropical Diseases, London School of Hygiene &amp; Tropical Medicine, London, United Kingdom"},{"name":"Medical Research Centre, The Fajara, Banjul, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel M.","family":"Dockrell","sequence":"additional","affiliation":[{"name":"Department of Infectious and Tropical Diseases, London School of Hygiene &amp; Tropical Medicine, London, United Kingdom"},{"name":"Medical Research Centre, The Fajara, Banjul, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(00)02742-2","volume":"356","year":"2000","unstructured":"Andersen, P., M. E. Munk, J. M. Pollock, and T. M. Doherty. 2000. Specific immune-based diagnosis of tuberculosis. Lancet356:1099-1104.","journal-title":"Lancet"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5419.1520"},{"key":"e_1_3_2_4_2","first-page":"664","volume":"5","year":"2001","unstructured":"Black, G. F., P. E. M. Fine, D. K. Warndorff, S. Floyd, R. E. Weir, J. M. Blackwell, L. Bliss, L. Sichali, L. Mwaungulu, S. Chaguluka, E. Jarman, B. Ngwira, and H. M. Dockrell. 2001. Relationship between IFN-gamma and skin test responsiveness to Mycobacterium tuberculosis PPD in healthy, non-BCG-vaccinated young adults in northern Malawi. Int. J. Tuberc. Lung Dis.5:664-672.","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"e_1_3_2_5_2","first-page":"462","volume":"5","year":"2001","unstructured":"Brock, I., M. E. Munk, A. Kok-Jensen, and P. Andersen. 2001. Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int. J. Tuberc. Lung Dis.5:462-467.","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.5.4.531-536.1998"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1473-3099(03)00545-0","volume":"3","year":"2003","unstructured":"Gardam, M. A., E. C. Keystone, R. Menzies, S. Manners, E. Skamene, R. Long, and D. C. Vinh. 2003. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect. Dis.3:148-155.","journal-title":"Lancet Infect. Dis."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1371\/journal.pone.0000068","volume":"1","year":"2006","unstructured":"Hill, P. C., R. H. Brookes, A. Fox, D. Jackson-Sillah, M. D. Lugos, D. J. Jeffries, S. A. Donkor, R. A. Adegbola, and K. P. McAdam. 2006. Surprisingly high specificity of the PPD skin test for M. tuberculosis infection from recent exposure in The Gambia. PLoS ONE1:e68.","journal-title":"PLoS ONE"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1086\/382362","volume":"38","year":"2004","unstructured":"Hill, P. C., R. H. Brookes, A. Fox, K. Fielding, D. J. Jeffries, D. Jackson-Sillah, M. D. Lugos, P. K. Owiafe, S. A. Donkor, A. S. Hammond, J. K. Otu, T. Corrah, R. A. Adegbola, and K. P. McAdam. 2004. Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin. Infect. Dis.38:966-973.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.1086\/313864","volume":"30","year":"2000","unstructured":"Hoft, D. F., R. M. Brown, and R. B. Belshe. 2000. Mucosal bacille calmette-Guerin vaccination of humans inhibits delayed-type hypersensitivity to purified protein derivative but induces mycobacteria-specific interferon-gamma responses. Clin. Infect. Dis.30(Suppl. 3):S217-S222.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.44.3.1197-1201.2006"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200402-179OC","volume":"170","year":"2004","unstructured":"Mori, T., M. Sakatani, F. Yamagishi, T. Takashima, Y. Kawabe, K. Nagao, E. Shigeto, N. Harada, S. Mitarai, M. Okada, K. Suzuki, Y. Inoue, K. Tsuyuguchi, Y. Sasaki, G. H. Mazurek, and I. Tsuyuguchi. 2004. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am. J. Respir. Crit. Care Med.170:59-64.","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/CDLI.12.4.491-496.2005","volume":"12","year":"2005","unstructured":"Ravn, P., M. E. Munk, \u00c5. B. Andersen, B. Lundgren, J. D. Lundgren, L. N. Nielsen, A. Kok-Jensen, P. Andersen, and K. Weldingh. 2005. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin. Diagn. Lab. Immunol.12:491-496.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1365-2249.1999.00892.x","volume":"116","year":"1999","unstructured":"Weir, R. E., P. J. Brennan, C. R. Butlin, and H. M. Dockrell. 1999. Use of a whole blood assay to evaluate in vitro T cell responses to new leprosy skin test antigens in leprosy patients and healthy subjects. Clin. Exp. Immunol.116:263-269.","journal-title":"Clin. Exp. Immunol."},{"key":"e_1_3_2_15_2","unstructured":"TB country profile Gambia 2005"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00093-07","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00093-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:38:29Z","timestamp":1627591109000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00093-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["10.1128\/CVI.00093-07"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00093-07","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6]]},"assertion":[{"value":"2007-02-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-04-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}